top of page
Young Doctor
Speclipse CI_white only_reversed-01.png

Detect the Invisible in an Instant

Speclipse CI_white only_reversed-01.png

The Best Technologies Brought to Light

Speclipse offers the world first cancer diagnostic solution based on Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) Technology. Spectra-Scope® is a lightweight, portable device that detects the biochemical information of skin tissue using laser-induced plasma spectroscopy (LIPS). It comes with a deep-learning AI-based diagnostic algorithm for fast and accurate oncological diagnostics.

As a leading manufacturer of state-of-the-art devices, Speclipse manufactures medical devices for precise and effective treatments for a wide range of skin lesions that empower dermatologists to achieve optimal results. Through years of research and development, backed by numerous patents that are advanced from the competition, Speclipse has developed the first two revolutionary laser devices called Pico-K and Bellus-Q.


      Speclipse, Inc.
      - 310 De Guigne Drive, Sunnyvale, CA 94085, USA

South Korea
      Speclipse, Inc. (Head Office)
      - 4th Floor, Gyeongchang Building, 141, Unjung-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea

      Speclipse, Inc. (Branch Office)
      - #501~#504, Sunplaza, 31, Jungbo-ro, Sangnok-gu, Ansan-si, Gyeonggi-do, South Korea

      Speclipse Europe GmbH
      - Am Kronberger Hang 2, Schwalbach, 658254, Germany

   Speclipse Australia Pty Ltd
   - 1313/93 MacDonald Street, Erskinville, NSW 2043, Australia


CE 2460.png
Medical Tech Outlook.png

© 2020 by Speclipse, Inc.


Skin Cancer Screening

Skin Cancer Screening
Workflow Streamlining
Revenue Enhancement
Cost Reduction

스크린샷 2024-04-23 오후 3.54_edited.png
스크린샷 2024-04-23 오후 3.49.35.png

Advanced Picosecond Laser

300 ps / 2 GW 

High Peak Power
Easy Maintenance
Power Factor Correction 

bottom of page